Clinical Trial Activity References Quality & Purity This product is synthesized via solid-phase peptide synthesis (SPPS) and tested to 99% purity by HPLC with identity confirmed by mass spectrometry
By increasing the amount of GLP-1 and GIP, the body produces more insulin, allowing more glucose to be transported from the blood to the cells that need it
Insulin resistance and chronic hyperglycemia cause a cascade of pathological events in the brain, including neuroinflammation, impaired neurotransmitter systems and energy metabolism, oxidative stress, and vascular pathologies that ultimately lead to neurodegeneration, loss of synaptic plasticity, brain aging, cognitive impairment, and dementia
doi: 10.1158/1940-6207.CAPR-14-0126
Occupational therapy goes hand in hand with PT to overcome the physical limitations that hinder patients including walking, manual activities, and self-transfers such as rising from a chair, all of which impact the lifestyle and activities within ones community and home
However, GLP-1 medications may still be covered for secondary medical indications